FOXP3 is traditionally used as a marker of CD4+ regulatory T-cells (T-reg), which were already implicated on immune suppression and worse prognosis of other lymphoma subtypes, such as follicular lymphoma [52]. Here, FOXP3 is linked to follicular lymphoma.